Neurocrine Biosciences (NBIX) Reports Q3 Loss of $0.13
Tweet
Share
E-mail
Get Alerts NBIX Hot Sheet
Price: $160.55 -1.33%
Revenue Growth %: +26.1%
Financial Fact:
Income (loss) from operations: -38.44M
Today's EPS Names:
PLCE, COE, JVA, More
Revenue Growth %: +26.1%
Financial Fact:
Income (loss) from operations: -38.44M
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q3 EPS of ($0.13), versus ($0.43) reported last year.
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- Vera Bradley (VRA) Misses Q1 EPS by 26c ; Offers Guidance
- Nvidia pitches Vera CPU to Chinese clients with August delivery target
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
